Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Breast cancer risk factors and HER2 over-expression in tumors.
Swede H, Moysich KB, Freudenheim JL, Quirk JT, Muti PC, Hurd TC, Edge SB, Winston JS, Michalek AM. Swede H, et al. Among authors: moysich kb. Cancer Detect Prev. 2001;25(6):511-9. Cancer Detect Prev. 2001. PMID: 12132871
Lactation history and breast cancer risk.
Freudenheim JL, Marshall JR, Vena JE, Moysich KB, Muti P, Laughlin R, Nemoto T, Graham S. Freudenheim JL, et al. Among authors: moysich kb. Am J Epidemiol. 1997 Dec 1;146(11):932-8. doi: 10.1093/oxfordjournals.aje.a009219. Am J Epidemiol. 1997. PMID: 9400334
Environmental organochlorine exposure and postmenopausal breast cancer risk.
Moysich KB, Ambrosone CB, Vena JE, Shields PG, Mendola P, Kostyniak P, Greizerstein H, Graham S, Marshall JR, Schisterman EF, Freudenheim JL. Moysich KB, et al. Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):181-8. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9521429
Regular use of analgesic drugs and ovarian cancer risk.
Moysich KB, Mettlin C, Piver MS, Natarajan N, Menezes RJ, Swede H. Moysich KB, et al. Cancer Epidemiol Biomarkers Prev. 2001 Aug;10(8):903-6. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11489759
A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease.
Hahn T, Benekli M, Wong C, Moysich KB, Hyland A, Michalek AM, Alam A, Baer MR, Bambach B, Czuczman MS, Wetzler M, Becker JL, McCarthy PL. Hahn T, et al. Among authors: moysich kb. Bone Marrow Transplant. 2005 Mar;35(6):557-66. doi: 10.1038/sj.bmt.1704789. Bone Marrow Transplant. 2005. PMID: 15665852
259 results